Valsartan Tablet, Film Coated
Product Images NDC 51655-456

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 51655-456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 456 52)

Label for Valsartan 160 mg film-coated tablets, containing 30 tablets. The label includes storage instructions, dosage guidance to see package insert, and manufacturer information for Northwind Health Company, LLC. The NDC 51655-456-52 is displayed along with batch and expiration data placeholders.*

FDA Label Image

111 (Valsartan Figure1)

A forest plot chart comparing Valsartan versus Captopril across various patient subgroups in a clinical study. The x-axis shows a scale from 0.5 to 1.5, indicating favor towards Valsartan or Captopril. Patient subgroups include age, gender, ethnicity, geographic location, and beta-blocker usage. Each subgroup has a point estimate with confidence intervals displayed as horizontal lines.*

FDA Label Image

Valsartan (Valsartan Structural Formula)

Chemical structure diagram of Valsartan, showing its molecular arrangement and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.